QIAGEN and DiaSorin launch automated testing for latent TB infection
QIAGEN and DiaSorin announced the introduction of an automated, CE-marked workflow for QIAGEN’s QuantiFERON-TB Gold Plus blood collection tubes (QFT-Plus BCT) and a novel DiaSorin LIAISON test on widely used immunodiagnostic instruments from DiaSorin. Laboratories in Europe and other markets will now be able to process QFT-Plus BCT, the fourth-generation modern gold standard for latent […]
